4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-26-015397
Options or other derivatives
- Chief Scientific Officer acquired 41,650 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Garfield Alastair Chief Scientific Officer | 2026-02-11 | Grant or award · Restricted Stock Units | +16,650 | 16,650 | D | ||
| Garfield Alastair Chief Scientific Officer | 2026-02-11 | Grant or award · Stock Options (Right to Buy) | +25,000 | 25,000 | D | ||
Loading xslF345X05/tm266366-2_4seq1.xml…